Neurofilament protein in cerebrospinal fluid: A marker of white matter changes
Abstract
The objective of this study was to compare cerebrospinal fluid (CSF) levels of the light subtype of the neurofilament proteins (NFL), tau, and beta-amyloid42 (Abeta42) in individuals with moderate or severe white matter changes (WMC) and in those with mild or no WMC. Twenty-two patients with Alzheimer's disease (AD), nine patients with subcortical vascular dementia (SVD), and 20 normal controls were included in the study. The occurrence of WMC was evaluated by a neuroradiologist using the Blennow-Wallin scale. Thirty-seven subjects had no or only punctate WMC; 14 had moderate to severe WMC. Both diagnostic group and WMC, but not gender or apolipoproteinE E4 inheritance, contributed to the variance in the CSF levels of tau, NFL, and Abeta42. In patients with moderate to severe WMC, CSF NFL (P < 0.01), but not CSF tau or CSF Abeta42, was increased also after correction for age, gender, and degree of cognitive impairment. A comparison between patients and controls with any signs of WMC and those without such signs yielded a similar result: CSF NFL (P < 0.001) was increased in the group with signs of WMC. As in numerous previous studies, we found that CSF tau was increased in AD (P < 0.001) compared with controls. Furthermore, CSF NFL was increased in both AD and SVD compared with controls (P < 0.001 for both). Although diagnostic group seems to be a stronger predictor of the variance found in CSF NFL, a clear association between the presence of WMC and increased CSF NFL was foun…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
NFL is a potential biomarker of WM damage.
“Since NFL is a potential biomarker of WM damage (Sjogren et al., 2001), we hypothesized that the levels of NFL would increase in mouse model of Aβ amyloidosis.”
From Disrupted structural connectivity in ArcAβ mouse model of Aβ amyloidosis (2020) · cites this paper as Sjogren et al., 2001
The citation lists haven’t been fetched yet
References 60 · Cited by 209
- Authors
- Sjögren, M., Blomberg, M., Jonsson, M., Wahlund, L. ‐., Edman, Å., Lind, K., Rosengren, L., Blennow, K., & Wallin, A.
- Affiliations
- University of Gothenburg (SE)
- Swedish Research Council (SE)
- Corresponding author
- Sjögren, M.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2001-10-25
- Volume
- 66
- Issue
- 3
- Pages
- 510-516
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W1977206425
- Cited by
- 209
- References
- 60
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 11 · 2023: 6 · 2022: 13 · 2021: 15 · 2020: 18 · 2019: 12 · 2018: 14 · 2017: 10 · 2016: 7 · 2015: 8 · 2014: 12 · 2013: 7 · 2012: 7
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neuroscience Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- The Alzheimer Foundation
- Clas Groschinsky's Foundation
- The Dementia Foundation
- Edit Jacobsons donationsfond
- Fredrik och Ingrid Thurings Stiftelse
- Gun and Bertil Stohne's Foundation
- Loo and Hans Osterman's Foundation for Medical Research
- Martina och Wilhelm Lundgrens Stiftelse
- Stiftelsen för Gamla Tjänarinnor
- Stiftelsen Handlanden Hjalmar Svenssons Forskningsfond
- Stiftelsen Lars Hiertas Minne
- Lundbeckfonden
- Pfannenstills forskningsfond
- The Swedish Association of Neurologically Disabled
- The Swedish Medical Society
- The Swedish Research Council (12103, 11560, 12769, 13121, 09946)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Neurology › Cerebrovascular and genetic disorders
- Keywords
- neurofilament light chain, cerebrospinal fluid biomarkers, white matter changes, tau protein, Alzheimer's disease, subcortical vascular dementia, axonal degeneration, APOE ε4
- MeSH terms
- Aged, Alzheimer Disease, Apolipoproteins E, Cerebral Cortex, Diagnosis, Differential, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Nerve Fibers, Myelinated, Peptide Fragments, Predictive Value of Tests, Serum Albumin, Sex Factors, Wallerian Degeneration, Dementia, Vascular, Biomarkers, Amyloid beta-Peptides, tau Proteins, Neurofilament Proteins, Disease Progression, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review